A pre-print paper authored by Japanese researchers warned against using blood from recipients of the COVID-19 vaccine for transfusions.
The researchers highlight the “variety of diseases involving all organs and systems” linked to COVID-19 inoculation, urging medical professionals to move away from “using blood products derived from people who have suffered from long
COVID and from genetic vaccine recipients, including those who have received mRNA vaccines.”
“[T]here is an undeniable risk that patients may experience some problems if they receive blood products derived from blood collected in, at least, a brief deferral period after genetic vaccination,” the authors explain, detailing concerns of neurotoxicity, infection, autoimmune disease, spike protein development, and chronic inflammation.
The authors proposed means of responding to blood contamination.
If a blood product may contain spike proteins from mRNA vaccination, the researchers suggest “mass spectrometry that can directly measure the protein itself.” Mass spectrometry can calculate the molecular weight of the protein.
The researchers also propose interviewing blood donors and collecting their vaccine history, as well as assessing symptoms of possible autoimmune disorders that may have been caused by the presence of spike proteins.
“At present, the genetic vaccination status of blood donors is not confirmed or controlled by organizations including medical institutions, and the use of blood collected from these donors for transfusions may pose risks to patients,” they write. “Therefore, when blood products derived from gene vaccine recipients are used, it is necessary to confirm the presence or absence of spike protein or modified mRNA as in other tests for pathogens.”
The authors emphasize that “it is essential” to remove spike proteins or modified genes from a blood product, although “there is currently no reliable way to do so.”
Because “there is no way to reliably remove the pathogenic protein or mRNA,” the authors note, “we suggest that all such blood products be discarded until a definitive solution is found.”
“Discarding blood products prepared from blood collected from many dedicated blood donors can be very painful, but it is necessary because the spike protein itself has been shown to induce thrombosis and similar diseases.”
The researchers conclude their paper by “strongly” requesting that the “vaccination campaign using genetic vaccines be suspended and that a harm–benefit assessment be carried out as early as possible.”
“As we have repeatedly stated, the health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organizations take concrete steps together to identify the risks and to control and resolve them.”